New advances in pharmacoresistant epilepsy towards precise management-from prognosis to treatments
C Xu, Y Gong, Y Wang, Z Chen - Pharmacology & Therapeutics, 2022 - Elsevier
Epilepsy, one of the most severe neurological diseases, is characterized by abrupt recurrent
seizures. Despite great progress in the development of antiseizure drugs (ASDs) based on …
seizures. Despite great progress in the development of antiseizure drugs (ASDs) based on …
Aberrant connection formation and glia involvement in the progression of Pharmacoresistant mesial temporal lobe epilepsy
A Vega-García, R Guevara-Guzmán… - Current …, 2022 - ingentaconnect.com
Epilepsy is the most common chronic neurological disease, affecting approximately 65
million people worldwide, with mesial temporal lobe epilepsy (mTLE) being the most …
million people worldwide, with mesial temporal lobe epilepsy (mTLE) being the most …